Anti-SLAMF7 Therapeutic Antibody (Elotuzumab)
Recombinant humanized antibody expressed in CHO binding to human SLAMF7/CD319. Elotuzumab is a humanized monoclonal antibody which is under phase III clinical investigation in relapsed multiple myeloma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-743 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | SLAMF7/CD319 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, IHC and most other immunological methods. |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |